ImmuCell Correlations

The current 90-days correlation between ImmuCell and Equillium is -0.11 (i.e., Good diversification). The correlation of ImmuCell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

ImmuCell Correlation With Market

Modest diversification

The correlation between ImmuCell and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ImmuCell and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Moving together with ImmuCell Stock

  0.63HD Home DepotPairCorr

Moving against ImmuCell Stock

  0.69AMGN Amgen IncPairCorr
  0.65KO Coca ColaPairCorr
  0.59MMM 3M CompanyPairCorr
  0.54GILD Gilead SciencesPairCorr
  0.53CSCO Cisco SystemsPairCorr
  0.48MRK Merck CompanyPairCorr
  0.47TRV The Travelers CompaniesPairCorr
  0.36XOM Exxon Mobil Corp Aggressive PushPairCorr
  0.31CAT CaterpillarPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

IPSCFBIO
GNTACUE
GNTANRXP
OSTXCUE
SNTICUE
NRXPCUE
  

High negative correlations

SNTIFBIO
NRXPOTLK
FBIOCUE
OTLKCUE
SNTIIPSC
IPSCCUE

Risk-Adjusted Indicators

There is a big difference between ImmuCell Stock performing well and ImmuCell Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ImmuCell's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
EQ  5.73  0.21  0.05  0.14  5.37 
 19.26 
 35.57 
CUE  4.99 (1.12) 0.00 (0.33) 0.00 
 10.00 
 45.83 
OTLK  5.19  0.83  0.13 (1.24) 5.27 
 12.74 
 30.35 
COEP  2.80 (0.30) 0.00 (0.26) 0.00 
 5.91 
 22.14 
OSTX  2.93 (0.75) 0.00 (0.32) 0.00 
 5.42 
 16.39 
NRXP  3.99 (0.33) 0.00 (0.13) 0.00 
 8.06 
 24.81 
FBIO  2.88  0.37  0.13  0.25  2.87 
 5.72 
 17.59 
IPSC  3.89  0.96  0.18  0.62  4.48 
 8.77 
 26.68 
SNTI  5.39 (0.50) 0.00 (0.12) 0.00 
 11.06 
 59.37 
GNTA  6.30 (0.57) 0.00 (0.16) 0.00 
 6.96 
 138.40 

ImmuCell Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ImmuCell stock to make a market-neutral strategy. Peer analysis of ImmuCell could also be used in its relative valuation, which is a method of valuing ImmuCell by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

ImmuCell Corporate Executives

Elected by the shareholders, the ImmuCell's board of directors comprises two types of representatives: ImmuCell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ImmuCell. The board's role is to monitor ImmuCell's management team and ensure that shareholders' interests are well served. ImmuCell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ImmuCell's outside directors are responsible for providing unbiased perspectives on the board's policies.
Timothy FioriSecretary, CFOProfile